Status:
COMPLETED
Efficacy and Safety of Itopride vs Placebo in Heartburn
Lead Sponsor:
Forest Laboratories
Conditions:
Heartburn
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the effects of itopride in patients with heartburn.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Otherwise healthy males and females aged 18-70, with at least 3 episodes of heartburn or acid regurgitation per week.
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00382577
Start Date
October 1 2006
End Date
December 1 2006
Last Update
February 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Oklahoma Foundation for Digestive Research
Oklahoma City, Oklahoma, United States, 73104